Home / Stocks / WST

West Pharmaceutical Services (WST, Life Sciences Tools & Services) Stock Valuation & Fair Value Significantly overvalued

West Pharmaceutical Services (WST, Life Sciences Tools & Services) trades at a blended P/E of 42.2, about 35% above its historical normal valuation, with a forward growth estimate of 14.0% and a PEG of 3.02. Analysts' one-year estimates have been hit 64% of the time.

DATA AS OF 2026-08-21
Blended P/E
42.2
Normal P/E
31.4
PEG
3.02
Fwd growth
14.0%
Div yield
0.2%
RSI (14)
49.3
Neutral

The Street vs SeerForecast

Wall Street's mean price target for WST is $404.73 across 15 analysts, 14.6% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-06-03.

Price and rating by weekClose moved +10.5 percent from 2026-06-03 to 2026-08-17, with 0 rating changes over 21 recorded weeks.2026-06-03: Significantly overvalued, close 316.10 (recalculated)2026-06-10: Significantly overvalued, close 330.70 (recalculated)2026-06-14: Significantly overvalued, close 328.61 (recalculated)2026-06-16: Significantly overvalued, close 329.36 (recalculated)2026-06-21: Significantly overvalued, close 327.74 (recalculated)2026-07-02: Significantly overvalued, close 365.50 (recalculated)2026-07-06: Significantly overvalued, close 357.41 (recalculated)2026-07-09: Significantly overvalued, close 357.43 (recalculated)2026-07-12: Significantly overvalued, close 353.48 (recalculated)2026-07-13: Significantly overvalued, close 359.47 (recalculated)2026-07-14: Significantly overvalued, close 357.42 (recalculated)2026-07-20: Significantly overvalued, close 352.09 (recalculated)2026-07-22: Significantly overvalued, close 358.18 (recalculated)2026-07-25: Significantly overvalued, close 327.99 (recalculated)2026-07-27: Significantly overvalued, close 331.03 (recalculated)2026-07-31: Significantly overvalued, close 340.96 (recalculated)2026-08-03: Significantly overvalued, close 340.962026-08-07: Significantly overvalued, close 354.07 (recalculated)2026-08-10: Significantly overvalued, close 354.072026-08-14: Significantly overvalued, close 349.42 (recalculated)2026-08-17: Significantly overvalued, close 349.423163492026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 41.1+31%Significantly overvalued
2026-06-10P/E 40.1+28%Significantly overvalued
2026-06-14P/E 40.1+28%Significantly overvalued
2026-06-16P/E 40.1+28%Significantly overvalued
2026-06-21P/E 40.1+28%Significantly overvalued
2026-07-02P/E 46.0+46%Significantly overvalued
2026-07-06P/E 46.0+47%Significantly overvalued
2026-07-09P/E 46.0+47%Significantly overvalued
2026-07-12P/E 44.4+41%Significantly overvalued
2026-07-13P/E 44.4+41%Significantly overvalued
2026-07-14P/E 44.4+41%Significantly overvalued
2026-07-20P/E 44.8+43%Significantly overvalued
2026-07-22P/E 44.8+43%Significantly overvalued
2026-07-25P/E 39.8+27%Significantly overvalued
2026-07-27P/E 39.8+27%Significantly overvalued
2026-07-31P/E 41.0+31%Significantly overvalued
2026-08-03P/E 41.2+31%Significantly overvalued
2026-08-07P/E 41.9+34%Significantly overvalued
2026-08-10P/E 42.6+36%Significantly overvalued
2026-08-14P/E 41.5+32%Significantly overvalued
2026-08-17P/E 41.9+33%Significantly overvalued
2026-08-21P/E 42.2+35%Significantly overvalued ← now

Frequently asked questions

Is West Pharmaceutical Services stock overvalued?

At a blended P/E of 42.2 versus its historical normal P/E of 31.4, West Pharmaceutical Services trades about 35% above its typical valuation, with a PEG of 3.02 on 14.0% forward growth. tickerseer currently rates it significantly overvalued.

What is West Pharmaceutical Services's fair value and PEG?

West Pharmaceutical Services trades at a blended P/E of 42.2 against a historical normal P/E of 31.4, a PEG of 3.02, and a forward growth estimate of 14.0%.

Has tickerseer's rating of West Pharmaceutical Services changed?

tickerseer's rating has been significantly overvalued since 2026-06-03.

What is the analyst price target for West Pharmaceutical Services?

The mean Wall Street price target for West Pharmaceutical Services is $404.73 across 15 analysts, 14.6% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track WST free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.